Most women do not start here because a procedure name caught their eye. They start here because something changed. Sex may feel drier. Arousal may take longer. Orgasm may feel weaker, or bladder leakage may start showing up during workouts, coughing, or laughter. Daily life can still look perfectly normal while something private keeps getting harder to ignore.
The O-Shot usually enters the picture after that. Not as a first idea. More often, it comes up after a woman realizes the problem is not fading on its own and the usual strategy of waiting, adapting, and hoping has run out of steam.
So the starting point should be the symptom, not the label. Less sensation during intimacy is one kind of complaint. Pain with penetration is another. Leakage during exercise is another again. Those symptoms can overlap, but they do not automatically come from the same mechanism, and no smart consultation should pretend otherwise.
Fort Myers clinic visit details
Fountain of Youth sees patients at 13720 Cypress Terrace Circle, Suite 303, Fort Myers, FL 33907.
Clinic hours are Monday through Friday from 7:00 am to 5:00 pm, Saturday from 7:00 am to 3:00 pm, and Sunday closed. For scheduling questions or to book a consultation, call 239-355-3294.
A consultation at the Fort Myers clinic should focus on the symptom that changed, what has already been tried, and whether this treatment makes sense or whether a broader women’s health evaluation would be the better next step.
What this treatment is
The O-Shot is a branded injection treatment made from a processed sample of your own blood. Cleveland Clinic describes it as an experimental procedure in which a clinician draws blood, prepares it, and injects it into intimate tissue. In plain terms, think blood draw and targeted injections, not lasers and not hormone therapy.
The branding can make the treatment sound more established than the evidence really allows. A polished name tends to suggest a clear medical lane, a settled result, and a standard candidate profile. The published literature does not support that level of confidence yet.
What women usually hope it may help
Sensation, arousal, and orgasm changes
This is where most of the interest starts. Cleveland Clinic notes that procedures in this category are often promoted around improved sensitivity, easier arousal, and stronger orgasms. That appeal makes sense when desire is still there but the physical response has become slower, duller, or harder to reach.
Still, “may help” should not get stretched into “usually works.” Some women are asking about weaker orgasm intensity. Others are wondering why the body no longer responds the way it once did even when interest is present. Those are real complaints. They just do not come with a clean promise attached.
Dryness, pain, and bladder leakage
The cleaner marketing pitch starts to wobble here. Cleveland Clinic also lists increased moisture, less painful intercourse, and help with urine leakage among the benefits these procedures commonly claim. That broad appeal is exactly why the treatment gets attention. It is also why women can end up evaluating the wrong problem.
Dryness may reflect menopause-related tissue change. Pain may point toward irritation, pelvic floor tension, or another gynecologic issue that deserves its own exam. Leakage during coughing, laughing, or exercise may call for a broader urogynecologic workup instead of a bundled intimacy treatment. Once those distinctions are on the table, the glossy version usually looks a lot less tidy.
What happens during the appointment
The visit itself is usually straightforward. Blood is drawn first. The sample is processed. The clinician then injects the prepared material into the target area. Cleveland Clinic identifies the clitoris and vagina as the usual injection sites.
Before booking, ask for specifics. Where exactly will the injections go? Why those locations? Which symptom is the treatment actually supposed to address? “Intimate wellness” is too vague once needles are involved.
Practical questions count too. Ask how the area may feel later that day, whether local soreness is common, and whether sex or exercise should wait. Those are not minor details. They are part of the decision.
Recovery and short-term considerations
Short-term recovery should be discussed plainly. Cleveland Clinic lists possible risks tied to intimate rejuvenation procedures such as pain, bleeding, infection, painful sex, numbness or unusual sensations, scarring, and the possibility of needing another procedure.
Needles are still needles. Even if the appointment is brief, the more useful question is what the treated area may feel like later that day, the next morning, and during normal activity. A woman already dealing with pain during sex may judge even temporary soreness very differently from someone whose main goal is less leakage while exercising.
Generic reassurance does not help much here. The likely benefit, the short-term downside, and the remaining uncertainty all need to sit in the same conversation.
Is the O-Shot FDA-approved for orgasm problems
What the published evidence actually shows
The evidence base is still developing, and patients should hear that without spin. A 2023 systematic review indexed in PubMed concluded that there is no clear evidence yet that these injections improve female sexual dysfunction or stress urinary incontinence, even though some small studies reported better patient-reported outcomes.
Useful signal, not proof. Positive patient reports may point to something worth studying. They do not show that the treatment works reliably, or that it works well enough to justify confident claims in routine marketing.
A 2026 randomized controlled trial indexed in PubMed shows that the subject is moving into more formal research, which is useful. One trial still does not settle a treatment category. The regulatory picture remains narrower than many patients assume. The FDA page covering 2024 biological device application approvals lists preparation systems indicated for bone graft handling, not for orgasm changes, vaginal dryness, or bladder leakage. For a patient weighing this option, that means there may be promise, but the uncertainty is real and it belongs in the room.
When a broader women’s health workup matters more
Not every intimate symptom belongs inside the same treatment bucket. Cleveland Clinic notes that symptoms often grouped under intimate rejuvenation may relate to aging, menopause, pelvic floor issues, or birth-related changes. That can sound like a footnote. It is not a footnote.
A woman may say desire feels lower when the harder problem is pain. Another may focus on orgasm changes even though the symptom disrupting daily life most is bladder leakage during running or coughing. When dryness is central, Cleveland Clinic notes that prescription estrogen-based treatment may need to be part of the discussion. When pain is central, a fuller gynecologic evaluation may matter more than any procedure with sleek branding. When leakage is central, the conversation may need to widen before it narrows.
Sometimes the more useful answer is the less glamorous one.
How to decide whether it fits your situation
O-Shot – How to decide whether it fits your situation
A good consultation usually starts with one blunt sentence: this is the symptom affecting my life the most. Once that is clear, the rest of the visit gets more precise. Ask what symptom the clinician thinks this treatment is most likely to address, why they think you are or are not a good candidate, what discomfort is typical afterward, and what alternatives make more sense if menopause-related tissue change or pelvic floor dysfunction appears to be the bigger driver.
At Fountain of Youth in Fort Myers, Florida, intimate-wellness consultations are usually more useful when the discussion stays concrete. What changed? When did it change? In what situations is it most obvious? What would meaningful improvement actually look like in daily life? Those details help separate a realistic next step from a branded maybe.
No woman needs to minimize an intimate symptom because it feels awkward to explain. Clear language helps. Realistic expectations help more. The decision should rest on the right problem, a sober reading of the evidence, and an honest view of what is still unknown.
Common questions women ask
Is the O-Shot FDA-approved for orgasm problems, dryness, or bladder leakage?
The FDA material reviewed here does not show an approval or clearance for using this treatment to address orgasm problems, intimate dryness, or bladder leakage. The FDA’s 2024 approvals page lists blood-processing systems indicated for bone graft handling, which is a different intended use. Cleveland Clinic also describes the O-Shot as experimental.
Could it still help some women even if the evidence is not settled?
Possibly, but the answer needs restraint. Some published studies reported better patient-reported outcomes, and newer research is more rigorous than earlier work. The overall evidence still does not support strong, across-the-board claims, so early promise should not be mistaken for proof.
What if dryness or pain during sex is the main issue?
That is when a broader workup often matters more. Dryness may relate to menopause-related tissue change, while pain can involve irritation, pelvic floor tension, or other gynecologic factors. A procedure-centered consultation can miss that distinction when the symptom history stays vague.
What should a woman bring up during the consultation?
The most helpful details are often the plainest ones. Explain when the symptom started, whether it is mainly about sensation, orgasm, dryness, pain, or leakage, what situations make it most obvious, and what improvement would actually feel meaningful. That gives the clinician something concrete to evaluate.
Questions? We are here to help! Call 239-355-3294.
